BIOCON Q2 FY27 ; CONS NET PROFIT DOWN 57% AT ₹57 CR (YOY), DOWN 59% (QOQ)

REVENUE UP 2% AT ₹4,389 CR (YOY), UP 1% (QOQ) EBITDA DOWN 1% AT ₹831 CR (YOY), DOWN 2% (QOQ) MARGINS AT 18.9% VS 19.4% (YOY), 19.5% (QOQ)

BIOCON LIMITED.